HIGH-RISK RECTAL CANCER NEO-ADJUVANT CAPECITABINE AND OXALIPLATIN BEFORE RADIOTHERAPY WITH CONCOMITANT CAPECITABINE AND RADICAL SURGERY LOCOREGIONAL RESPONSE

被引：0
|
作者：
Brodmann, S. [1 ]
Bateman, A. C.
Bateman, A. [1 ]
机构：
[1] Southampton Gen Hosp, Radiotherapy Ctr, Southampton, Hants, England
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：724 / 725
页数：2
相关论文
共 50 条
  • [31] Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes
    Gash, K. J.
    Baser, O.
    Kiran, R. P.
    EJSO, 2017, 43 (11): : 2052 - 2059
  • [32] Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II–III rectal cancer
    Ramon Salazar
    Matilde Navarro
    Ferran Losa
    Vicente Alonso
    Manel Gallén
    Fernando Rivera
    Manuel Benavides
    Pilar Escudero
    Encarnación González
    Bartomeu Massutí
    Auxiliadora Gómez
    Margarita Majem
    Enrique Aranda
    Clinical and Translational Oncology, 2012, 14 : 592 - 598
  • [33] Successful Downstaging of High Rectal and Recto-Sigmoid Cancer by Neo-Adjuvant Chemo-Radiotherapy
    O'Neill, Brian
    Brown, Gina
    Wotherspoon, Andrew
    Burton, Sarah
    Norman, Andy
    Tait, Diana
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 135 - 144
  • [34] Phase II Trial of Neoadjuvant Oxaliplatin and Capecitabine (XELOX) and Bevacizumab Without Radiotherapy for Poor-risk Rectal Cancer
    Uehara, K.
    Hiramatsu, K.
    Maeda, A.
    Sakamoto, E.
    Inoue, M.
    Kobayashi, S.
    Tojima, Y.
    Yoshioka, Y.
    Nakayama, G.
    Ohmiya, N.
    Kodera, Y.
    Goto, H.
    Nagino, M.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S12 - S13
  • [35] Tolerability of neo-adjuvant chemoradiotherapy (nCRT) with capecitabine and surgical outcomes in patients aged 70 years or older with locally advanced rectal cancer (LARC).
    Jacobs, Lotte
    van der Vlies, Ellen
    Huinink, Daan ten Bokkel
    Bloemendal, Haiko
    Smits, Anke B.
    Siersema, Peter. D.
    Weusten, Bas L. A. M.
    van Lelyveld, Niels
    Los, Maartje
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Utilization of capecitabine-oxaliplatin (CAPOX) versus infusional 5-fluorouracil and oxaliplatin (FFOX) in the adjuvant treatment (AT) of resected high-risk colon cancer.
    Sha, Aaron
    Abadi, Shirin
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy
    S Papagrigoriadis
    British Journal of Cancer, 2006, 95 : 950 - 950
  • [38] Locoregional Control Following Adjuvant Chemotherapy and Radiotherapy for Treatment of High-Risk Endometrial Cancer
    Babadagli, E.
    Kulkarni, A.
    Le, T.
    Fung-Kee-Fung, M.
    Lupe, K.
    Gaudet, M.
    Samant, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E269 - E270
  • [39] High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy
    Papagrigoriadis, S.
    BRITISH JOURNAL OF CANCER, 2006, 95 (07) : 950 - 950
  • [40] Impact of timing of adjuvant radiotherapy on locoregional control in patients with high-risk endometrial cancer
    Diaz-cazares, Omar
    Olimon, Cipatli
    Valles, Adrian
    Sanchez, Irving
    Balderrama, Ricardo
    Fuentes, Jesus
    Rodriguez, Jose
    Saavedra, Carlos
    Ayala-Hernandez, Luis E.
    Villalvazo-Anaya, Alejandro
    Mireles-Ramirez, Mario A.
    Chavez, Allan Hernandez
    Bayardo, Luis H.
    Gutierrez-Valencia, Enrique
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2023, 9
12345